Caffeic Acid Phenethyl Ester: Consequences of Its Hydrophobicity in the Oxidative Functions and Cytokine Release by Leukocytes


Autoria(s): Paracatu, Luana Chiquetto; Quinello Gomes Faria, Carolina Maria; Quinello, Camila; Renno, Camila; Palmeira, Patricia; Zeraik, Maria Luiza; Fonseca, Luiz Marcos da; Ximenes, Valdecir Farias
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

18/03/2015

18/03/2015

01/01/2014

Resumo

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Numerous anti-inflammatory properties have been attributed to caffeic acid phenethyl ester (CAPE), an active component of propolis. NADPH oxidases are multienzymatic complexes involved in many inflammatory diseases. Here, we studied the importance of the CAPE hydrophobicity on cell-free antioxidant capacity, inhibition of the NADPH oxidase and hypochlorous acid production, and release of TNF-alpha and IL-10 by activated leukocytes. The comparison was made with the related, but less hydrophobic, caffeic and chlorogenic acids. Cell-free studies such as superoxide anion scavenging assay, triene degradation, and anodic peak potential (E-pa) measurements showed that the alterations in the hydrophobicity did not provoke significant changes in the oxidation potential and antiradical potency of the tested compounds. However, only CAPE was able to inhibit the production of superoxide anion by activated leukocytes. The inhibition of the NADPH oxidase resulted in the blockage of production of hypochlorous acid. Similarly, CAPE was the more effective inhibitor of the release of TNF-alpha and IL-10 by Staphylococcus aureus stimulated cells. In conclusion, the presence of the catechol moiety and the higher hydrophobicity were essential for the biological effects. Considering the involvement of NADPH oxidases in the genesis and progression of inflammatory diseases, CAPE should be considered as a promising anti-inflammatory drug.

Formato

13

Identificador

http://dx.doi.org/10.1155/2014/793629

Evidence-based Complementary And Alternative Medicine. New York: Hindawi Publishing Corporation, 13 p., 2014.

1741-427X

http://hdl.handle.net/11449/117240

10.1155/2014/793629

WOS:000344095800001

WOS000344095800001.pdf

WOS000344095800001.epub

Idioma(s)

eng

Publicador

Hindawi Publishing Corporation

Relação

Evidence-based Complementary And Alternative Medicine

Direitos

openAccess

Tipo

info:eu-repo/semantics/article